We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Malignant tissues exhibited weak to moderate cytoplasmic immunoreactivity. Malignant lymphomas, melanomas, gliomas, cervical and prostate cancers were generally negative.
Several pancreatic, endometrial, renal and ovarian cancers showed moderate cytoplasmic staining. Remaining malignancies were weakly stained or negative.
GENE INFORMATION
Gene name
CFI (HGNC Symbol)
Synonyms
C3b-INA, FI, IF, KAF
Description
Complement factor I (HGNC Symbol)
Entrez gene summary
This gene encodes a serine proteinase that is essential for regulating the complement cascade. The encoded preproprotein is cleaved to produce both heavy and light chains, which are linked by disulfide bonds to form a heterodimeric glycoprotein. This heterodimer can cleave and inactivate the complement components C4b and C3b, and it prevents the assembly of the C3 and C5 convertase enzymes. Defects in this gene cause complement factor I deficiency, an autosomal recessive disease associated with a susceptibility to pyogenic infections. Mutations in this gene have been associated with a predisposition to atypical hemolytic uraemic syndrome, a disease characterized by acute renal failure, microangiopathic hemolytic anemia and thrombocytopenia. Primary glomerulonephritis with immmune deposits is another condition associated with mutation of this gene. [provided by RefSeq, Jul 2008]